Evidence map›Paper›PMID 24747015›Full record

ArticleGene2014

A conserved RNA polymerase III promoter required for gammaherpesvirus TMER transcription and microRNA processing.

Kevin W Diebel, David J Claypool, Linda F van Dyk

Abstract read
In one paragraph

Article in Gene, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Kevin W DiebelProgram in Molecular Biology, University of Colorado School of Medicine, Aurora, CO 80045, USA; Department of Microbiology, University of Colorado School of Medicine, Aurora, CO 80045, USA. Electronic address: kwdiebel@d.umn.edu.
David J ClaypoolDepartment of Microbiology, University of Colorado School of Medicine, Aurora, CO 80045, USA.
Linda F van DykProgram in Molecular Biology, University of Colorado School of Medicine, Aurora, CO 80045, USA; Department of Microbiology, University of Colorado School of Medicine, Aurora, CO 80045, USA; Department of Immunology, University of Colorado School of Medicine, Aurora, CO 80045, USA. Electronic address: Linda.VanDyk@ucdenver.edu.
University of Colorado Denver · US

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
U of Colorado Center for AIDS ResearchP30AI054907 · NIAID · UNIVERSITY OF COLORADO DENVER · PI MAWHINNEY-DELSON, SAMANTHA · 2003 to 2008
$9.6M
NEUROVIROLOGY-MOLECULAR BIOLOGYT32NS007321 · NINDS · UNIVERSITY OF COLORADO DENVER · PI GILDEN, DONALD · 1988 to 2014
$2.3M
Cyclin requirements in gammaherpesvirus infection and diseaseR01CA168558 · NCI · UNIVERSITY OF COLORADO DENVER · PI VAN DYK, LINDA F. · 2012 to 2016
$1.5M
In Vivo Analysis of Viral CyclinR01CA103632 · NCI · UNIVERSITY OF COLORADO DENVER · PI VAN DYK, LINDA F. · 2004 to 2008
$1.4M
Regulation of Herpesvirus Infection by Viral miRNAsR56AI091994 · NIAID · UNIVERSITY OF COLORADO DENVER · PI VAN DYK, LINDA F. · 2012 to 2012
$368k
NCI NIH HHS P30 CA046934NCI NIH HHS R01 CA103632NCI NIH HHS R01CA103632NCI NIH HHS R01 CA168558NIAID NIH HHS P30 AI054907NIAID NIH HHS R56 AI091994NIAID NIH HHS R56AI091994NINDS NIH HHS 2T32NS7321-2NINDS NIH HHS T32 NS007321
6 · The paper itself

Abstract

Canonical RNA polymerase III (pol III) type 2 promoters contain a single A and B box and are well documented for their role in tRNA and SINE transcription in eukaryotic cells. The genome of Murid herpesvirus 4 (MuHV-4) contains eight polycistronic tRNA-microRNA encoded RNA (TMER) genes that are transcribed from a RNA pol III type 2-like promoter containing triplicated A box elements. Here, we demonstrate that the triplicated A box sequences are required in their entirety to produce functional MuHV-4 miRNAs. We also identify that these RNA pol III type 2-like promoters are conserved in eukaryotic genomes. Human and mouse predicted tRNA genes containing these promoters also show enrichment of alternative RNA pol III transcription termination sequences and are predicted to give rise to longer tRNA primary transcripts.

Indexed as

Transcription, Genetic3T3 CellsAnimalsBase SequenceBlotting, NorthernFibroblastsGene Expression Regulation, ViralGenome, ViralHost-Pathogen InteractionsHumansMiceMicroRNAsMolecular Sequence DataMutagenesis, Site-DirectedPolyproteinsPromoter Regions, GeneticMicroRNAsPolyproteinsRNA Polymerase IIIRNA, TransferRNA, ViralA boxGammaherpesvirus 68tRNAType 2 promoter

Identifiers

PMID24747015
PMCPMC4544698
OpenAlexW2047013570

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.